We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Patients should not stop any treatments without consulting their doctor or pharmacist.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today given approval for the first monoclonal antibody treatment for the prevention and treatment of COVID-19 in the UK.…
First published during the 2019 to 2022 Johnson Conservative government
A new report highlights opportunities for the UK to take advantage of its departure from the EU and create UK-specific regulation that puts patients first.
The Health Secretary and the Business Secretary have responded to recommendations made by the Regulatory Horizons Council (RHC) about the regulation of medical devices.
This letter provides information on the introduction of the Shingrix® vaccine for immunocompromised individuals from 1 September 2021.
The UK regulator has confirmed the vaccine is safe and effective in this age group.
Nuromol, a medicine that contains 200mg of ibuprofen and 500mg of paracetamol per tablet will become available without the need to visit a pharmacy
We are seeking the views of industry, the medical community, patients and the public. The consultation will run for six weeks.
Patients should not stop any treatments without consulting their doctor or pharmacist
Extensive real-world data shows vaccines are safe and highly effective for pregnant women.
The public and healthcare professionals are being warned to take care when purchasing infrared thermometers online and to familiarise themselves with warning signs for poor quality products.
This letter provides information on the introduction of the Gardasil® 9 vaccine during the 2021 to 2022 academic year.
Health and Social Care Secretary Sajid Javid accepts advice from Joint Committee on Vaccination and Immunisation to offer vaccines to vulnerable young people.
This work will help ensure the safety of medicines and devices that reach the UK public and health service.
The collaboration aims to support China’s regulator in strengthening their regulatory capacity to improve patient access to safe and high-quality medicines and to promote global health security.
The Medicines and Healthcare products Regulatory Agency is playing a pivotal role helping to ensure that the UK remains one of the best places in the world to deliver safe, cutting-edge research.
More than 35 million have now received both doses of a COVID-19 vaccine – hitting the Prime Minister’s target almost a week early.
Pharmacists Dean Dookhan and Narvinder Nandra diverted hundreds of thousands of doses of prescription medicines, controlled as Class C drugs, from the legal supply chain onto the black market.
Progestogen-only contraceptive pills will be available for the first time from pharmacies without prescription, increasing choice for women in the ways in which they can access contraception.
The Medicines and Healthcare products Regulatory Agency (MHRA) and Health Canada have published guidance to improve the safety of patients in clinical trials through improved quality of the periodic safety reports known as Development Safety Update Reports (DSURs).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).